The Benefits of Platelet Glycoprotein IIb/IIIa Receptor Inhibition During Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction-Reference-Cited by-同舟云学术

The Benefits of Platelet Glycoprotein IIb/IIIa Receptor Inhibition During Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction

Published:2009-05 Issue:18 Volume:53 Page:1674-1676
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Brener Sorin J.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference17 articles.

1. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials;Keeley;Lancet,2003

2. Abolition of in vivo platelet thrombus formation in primates with monoclonal antibodies to the platelet GPIIb/IIIa receptor (correlation with bleeding time, platelet aggregation, and blockade of GPIIb/IIIa receptors);Coller;Circulation,1989

3. Intravenous glycoprotein IIb/IIIa receptor antagonists reduce mortality after percutaneous coronary interventions;Karvouni;J Am Coll Cardiol,2003

4. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials;Boersma;Lancet,2002

5. GPIIb/IIIa inhibitor-induced dethrombosis;Furman;J Thromb Thrombolysis,2004

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Abciximab in the management of acute myocardial infarction with ST-segment elevation: evidence-based treatment, current clinical use, and future perspectives;Therapeutics and Clinical Risk Management;2014-07

2. Diagnosis and treatment of platelet hyperactivity in relation to thrombosis in dogs and cats;Journal of Veterinary Emergency and Critical Care;2012-02

3. Glycoprotein IIb/IIIa Antagonists in Acute Coronary Syndromes Undergoing PCI: A Long Way to Select Optimal Agent and Route;ISRN Vascular Medicine;2011-07-09

4. Upstream tirofiban reduces reperfusion cardiac arrhythmias in patients of acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention;International Journal of Cardiology;2011-01

5. Long-term efficacy of high-dose tirofiban versus double-bolus eptifibatide in patients undergoing percutaneous coronary intervention;Journal of Cardiovascular Medicine;2011-01